DealsSK Capital buys SEQENSSK Capital has acquired SEQENS, a provider of pharmaceutical solutions and specialty ingredients.ByIris Dorbian17 December 2021•3 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs